Âðà÷ âûñøåé êàòåãîðèè
Ñîñóäèñòûé õèðóðã, Ôëåáîëîã, ÓÇÈ-ñïåöèàëèñò, Ëèìôîëîã, Àíãèîõèðóðã
Ïðèåì îò 3000
Âðà÷ ïðèíèìàåò â ñëåäóþùèõ êëèíèêàõ:
Ñòîèìîñòü ïðè¸ìà â «Ìåäèöèíñêèé öåíòð Ãåâäè»
Àäðåñ: ïð-ò Ïðîñâåùåíèÿ ä. 99, ëèò. À, ïîìåù. 32-Í
Ìåòðî: Ãðàæäàíñêèé ïðîñïåêò
Îáùèå ñâåäåíèÿ
- Îáñëåäîâàíèå è ëå÷åíèå ïàöèåíòîâ ñ âàðèêîçíîå ðàñøèðåíèå âåí íèæíèõ êîíå÷íîñòåé, ìàëîãî òàçà, âóëüâû è ïðîìåæíîñòè;
- âûïîëíåíèå ìàëîèíâàçèâíîå îïåðàòèâíîå ëå÷åíèå âàðèêîçíîå ðàñøèðåíèå âåí;
- ëå÷åíèå âàðèêîçà ñ ëàçåðîì;
- ìèêðîìèíèôëåáýêòîìèÿ;
- ñêëåðîòåðàïèÿ;
- ëå÷åíèå òðîôè÷åñêèõ ÿçâ íà ôîíå âàðèêîçíîé áîëåçíè, îáëèòåðèðóþùåãî àòåðîñêëåðîçà è ñàõàðíîãî äèàáåòà;
- âûïîëíåíèå óçè âåí íèæíèõ êîíå÷íîñòåé.
Îáðàçîâàíèå
- Äèïëîì ïî ñïåöèàëüíîñòè "Ëå÷åáíîå äåëî", Ôåäåðàëüíîå ãîñóäàðñòâåííîå áþäæåòíîå îáðàçîâàòåëüíîå ó÷ðåæäåíèå âûñøåãî îáðàçîâàíèÿ Ñåâåðî-çàïàäíûé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò èì. È.È.Ìå÷íèêîâà Ìèíèñòåðñòâà çäðàâîîõðàíåíèÿ Ðîññèéñêîé Ôåäåðàöèè (2014 ã.)
- Îðäèíàòóðà ïî ñïåöèàëüíîñòè "Ñåðäå÷íî-ñîñóäèñòàÿ õèðóðãèÿ", Ôåäåðàëüíîå ãîñóäàðñòâåííîå áþäæåòíîå îáðàçîâàòåëüíîå ó÷ðåæäåíèå âûñøåãî îáðàçîâàíèÿ Ñåâåðî-çàïàäíûé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò èì. È.È.Ìå÷íèêîâà Ìèíèñòåðñòâà çäðàâîîõðàíåíèÿ Ðîññèéñêîé Ôåäåðàöèè (2017 ã.)
- Àñïèðàíòóðà ïî ñïåöèàëüíîñòè "Ñåðäå÷íî-ñîñóäèñòàÿ õèðóðãèÿ", Ñàíêò-Ïåòåðáóðãñêèé ãîñóäàðñòâåííûé ïåäèàòðè÷åñêèé ìåäèöèíñêèé óíèâåðñèòåò (2020 ã.)
Ïîâûøåíèå êâàëèôèêàöèè
- "Àêòóàëüíûå âîïðîñû õèðóðãèè", Åæåãîäíàÿ êîíôåðåíöèÿ õèðóðãîâ Ñàíêò-Ïåòåðáóðãà "Ðàöèîíàëüíàÿ ôàðìàêîòåðàïèÿ â êëèíèêå âíóòðåííèõ áîëåçíåé", Êîíôåðåíöèÿ Àññîöèàöèè òåðàïåâòîâ Ñàíêò-Ïåòåðáóðãà "Ýíäîâàñêóëÿðíàÿ òðîìáýêòîìèÿ VS ôàðìàêîëîãè÷åñêèé òðîìáîëèçèñ" "Ñòðàòåãèÿ ×èñòîé âåíû" "Ëàçåðíàÿ ôëåáîëîãèÿ", Íàó÷íî-ïðàêòè÷åñêàÿ êîíôåðåíöèÿ "Ëàçåðíûå òåõíîëîãèè â ëå÷åíèè ñîñóäèñòûõ ïàòîëîãèé. Êëèíè÷åñêèé îïûò ïðèìåíåíèÿ íåîäèìîâîãî ëàçåðà FriendlyLight Neo", Íàó÷íî-ïðàêòè÷åñêàÿ êîíôåðåíöèÿ "Êîíñåðâàòèâíîå ëå÷åíèÿ õðîíè÷åñêîé âåíîçíîé íåäîñòàòî÷íîñòè" ""10-ûé Ñàíêò-Ïåòåðáóðãñêèé âåíîçíûé ôîðóì (2017 ã.)
- ""11-é Ñàíêò-Ïåòåðáóðãñêèé Âåíîçíûé Ôîðóì (2018 ã.)
- "Àêòóàëüíûå âîïðîñû õèðóðãè÷åñêîé èíôåêöèè: ñîâðåìåííûé ìóëüòèäèñöèïëèíàðíûé ïîäõîä â ëå÷åíèè õèðóðãè÷åñêîé èíôåêöèè", VI íàó÷íî-ïðàêòè÷åñêàÿ êîíôåðåíöèÿ (2018 ã.)
- "Ëå÷åíèå èøåìèè, óãðîæàþùåé êîíå÷íîñòè. Íîâûå òåõíîëîãèè è ýôôåêòèâíûå ðåøåíèÿ" (2018 ã.)
- "Ñîâðåìåííàÿ ëàçåðíàÿ ôëåáîëîãèÿ" (2018 ã.)
- "II Øêîëà ëèìôîëîãîâ" (2018 ã.)
- "Ïðèêëàäíûå àñïåêòû ñîñóäèñòîé õèðóðãèè, èíòåðâåíöèîííîé ðàäèîëîãèè è ôëåáîëîãèè", Âòîðîé Ñàíêò-Ïåòåðáóðãñêèé ïðàêòè÷åñêèé êóðñ (2018 ã.)
- "Òðîìáîçû è òðîìáîýìáîëèè â ïðàêòèêå âðà÷åé ðàçíûõ ñïåöèàëüíîñòåé", 5-ÿ êîíôåðåíöèÿ Îáðàçîâàòåëüíîãî Ïðîåêòà (2018 ã.)
- "ANGIOPICTURE" (2018 ã.)
- "Ëå÷åíèå êðèòè÷åñêîé èøåìèè íèæíèõ êîíå÷íîñòåé ÊÈÍÊ" (2018 ã.)
- "Ìåæäóíàðîäíàÿ íàó÷íî-ïðàêòè÷åñêàÿ êîíôåðåíöèÿ LINC" (2018 ã.)
- "Âàðèêîçíàÿ áîëåçíü: îò ýñòåòè÷åñêîé õèðóðãèè äî ëå÷åíèÿ îñëîæíåíèé", Ôëåáîëîãè÷åñêèé ôîðóì Áåëûå íî÷è (2018 ã.)
- "Ïðîôèëàêòèêà è ëå÷åíèå âåíîçíûõ òðîìáîýìáîëè÷åñêèõ îñëîæíåíèé" (2018 ã.)
- "Ýñòåòè÷åñêàÿ ôëåáîëîãèÿ" (2018 ã.)
- "Àêòóàëüíûå âîïðîñû õèðóðãè÷åñêîé èíôåêöèè: ñîâðåìåííûé ìóëüòèäèñöèïëèíàðíûé ïîäõîä â ëå÷åíèè õèðóðãè÷åñêèõ èíôåêöèé", Ãîðîäñêàÿ áîëüíèöà ¹ 14 (2018 ã.)
- "Îñëîæíåíèÿ è ïóòè ðåøåíèÿ â åæåäíåâíîé ïðàêòèêå ñîñóäèñòîãî õèðóðãà", Åëèçàâåòèíñêàÿ áîëüíèöà (2019 ã.)
- "Ìåæâóçîâñêàÿ âñåðîññèéñêàÿ ôëåáîëîãè÷åñêàÿ êîíôåðåíöèÿ áåëûå íî÷è îñåííèé ýòàï" (2019 ã.)
- "Àíãèîëîãèÿ è àíãèîõèðóðãèÿ â òðàâìàòîëîãèè è îðòîïåäèè", XLII çàñåäàíèå ýêñïåðòîâ-àíãèîêëóáà Ñàíêò-Ïåòåðáóðãà (2019 ã.)
- "Õðîíè÷åñêèå çàáîëåâàíèÿ âåí: ïàöèåíòî-îðèåíòèðîâàííûé ïîäõîä" (2019 ã.)
- "VI Åæåãîäíûé òíàñðàäèêàëüíûé êóðñ ÒÐÝÊ-2019" (2019 ã.)
- "Àêòóàëüíûå âîïðîñû õèðóðãè÷åñêîé èíôåêöèè: ñîâðåìåííûé ìóëüòèäèñöèïëèíàðíûé ïîäõîä", VI íàó÷íî-ïðàêòè÷åñêàÿ êîíôåðåíöèÿ (2019 ã.)
- "Òðîôè÷åñêàÿ ÿçâà - âå÷íàÿ ïðîáëåìà?", XLIII çàñåäàíèå Àíãèîêëóáà (2019 ã.)
- "Òðîìáîçû, êðîâîòî÷èâîñòü, ïîñòîÿííîå âíóòðèñîñóäèñòîå ñâåðòûâàíèå êðîâè", XXII Íàöèîíàëüíûé êîíãðåññ ñ ìåæäóíàðîäíûì ó÷àñòèåì (2019 ã.)
- "Èííîâàöèÿ â ëå÷åíèè ÈÁÑ è çàáîëåâàíèé ïåðèôåðè÷åñêèõ àðòåðèé", Êîíôåðåíöèÿ Êñàðåëòî (2019 ã.)
- "Âíåäðåíèå âûñîêèõ òåõíîëîãèé â ñîñóäèñòóþ õèðóðãèþ è ôëåáîëîãèþ", XXXV ìåæäóíàðîäíàÿ êîíôåðåíöèÿ (2019 ã.)
- "Íåðåøåííûå âîïðîñû â ëå÷åíèè çàáîëåâàíèé àîðòû, ïåðèôåðè÷åñêèõ àðòåðèé, âåí è ïðîôèëàêòèêè èíñóëüòà - íîâåéøèå òåíäåíöèè, êîíöåïöèè è ïåðñïåêòèâû", 3-ÿ Ðîññèéñêî-Ôèíñêàÿ êîíôåðåíöèÿ (2019 ã.)
- "Ïðîôèëàêòèêà âíóòðèñåðäå÷íûõ è âåíîçíûõ òðîìáîçîâ: äîñòèæåíèÿ è ïåðñïåêòèâû", INNOVATE Êîíôåðåíöèÿ (2019 ã.)
- "Ñïàñåíèå êîíå÷íîñòåé, ìóëüòèäèñöèïëèíàðíûé ïîäõîä", V þáèëåéíàÿ íàó÷íî-ïðàêòè÷åñêàÿ êîíôåðåíöèÿ (2019 ã.)
- "Ýíäîâàñêóëÿðíûå ðåøåíèÿ ïðè õèðóðãè÷åñêèõ êðîâîòå÷åíèÿõ è òðàâìàõ", Êîíôåðåíöèÿ ìåæäóíàðîäíîãî îáùåñòâà EVTM (2019 ã.)
- "Åæåãîäíàÿ ôëåáîëîãè÷åñêàÿ êîíôåðåíöèÿ Áåëûå íî÷è-2019" (2019 ã.)
- "Óëüòðàçâóêîâàÿ äèàãíîñòèêà", ×àñòíîå îáðàçîâàòåëüíîå ó÷ðåæäåíèå äîïîëíèòåëüíîãî ïðîôåññèîíàëüíîãî îáðàçîâàíèÿ Àêàäåìèÿ ïîâûøåíèÿ êâàëèôèêàöèè è ïðîôåññèîíàëüíîé ïåðåïîäãîòîâêè (2019 ã.)
- "Äèàãíîñòèêà è ëå÷åíèå àòåðåñêëåðîçà", 9-ÿ Ñàíêò-Ïåòåðáóðãñêàÿ øêîëà (2019 ã.)
- "Ãèáðèäíûå òåõíîëîãèè â ëå÷åíèè ñåðäå÷íî-ñîñóäèñòûõ çàáîëåâàíèé", XI Ìåæäóíàðîäíàÿ êîíôåðåíöèÿ (2020 ã.)
- "Äèàãíîñòèêà è ëå÷åíèå àòåðîñêëåðîçà", 10-àÿ Ñàíêò-Ïåòåðáóðãñêàÿ Øêîëà (2020 ã.)
- "Äèàáåòè÷åñêàÿ ñòîïà: âçãëÿä ýíäîêðèíîëîãà è àíãèîõèðóðãà", XLIII çàñåäàíèå ÀíãèîÊëóáà (2020 ã.)
Ìåñòà ðàáîòû
- Ìåäêëåâåð, ãîðîä Ñàíêò-Ïåòåðáóðã (2021 ã.)
- Ìåäèöèíñêèé öåíòð Äèîíà íà Ëóíà÷àðñêîãî, ãîðîä Ñàíêò-Ïåòåðáóðã (2022 ã.)
×ëåíñòâî â Àññîöèàöèÿõ
- ×ëåí Àññîöèàöèè Ôëåáîëîãîâ Ðîññèè ×ëåí Àññîöèàöèè ôëåáîëîãîâ Ñàíêò-Ïåòåðáóðãà ×ëåí Ðîññèéñêîå Îáùåñòâî àíãèîëîãîâ è ñîñóäèñòûõ õèðóðãîâ ×ëåí Àññîöèàöèè ñåðäå÷íî-ñîñóäèñòûõ õèðóðãîâ Ðîññèè ×ëåí drgalen.
- org, Empowering Patients & Doctors ×ëåí ìåæäóíàðîäíîãî ñîþçà àíãèîëîãîâ.
Ìóñëèìàõîí íàïèñàëà 14.03.2025
î âðà÷å, â êëèíèêå: Ìåäèöèíñêèé öåíòð Âèêîíò
Àðøåä Àõìàä ïðîâåë êîíñóëüòàöèþ è ñäåëàë ÓÇÈ. Îí âñ¸ ñïðîñèë è îáúÿñíèë! Ýòî áûë ìîé ïåðâè÷íûé ïðèåì. Äîêòîð âåæëèâûé. Ïî èòîãó ïðåäëîæèë ëå÷åíèå. ß ìíîãî ÷åãî ïîëåçíîãî ïîëó÷èëà äëÿ ñåáÿ.
âðà÷:
îòíîøåíèå:
êâàëèôèêàöèÿ:
öåíà-êà÷åñòâî: